DERM
Journey Medical Corp

3,066
Mkt Cap
$218.99M
Volume
85,095.00
52W High
$9.40
52W Low
$3.54
PE Ratio
-21.98
DERM Fundamentals
Price
$8.07
Prev Close
$7.83
Open
$7.90
50D MA
$7.74
Beta
0.65
Avg. Volume
164,621.70
EPS (Annual)
-$0.7181
P/B
8.22
Rev/Employee
$1.37M
Loading...
Loading...
News
all
press releases
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts
Journey Medical Corporation (NASDAQ:DERM - Get Free Report) has earned a consensus recommendation of "Hold" from the five brokerages that are presently covering the firm, Marketbeat Ratings reports...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
FY2025 EPS Forecast for Journey Medical Decreased by Analyst
Journey Medical Corporation (NASDAQ:DERM - Free Report) - Equities research analysts at HC Wainwright cut their FY2025 EPS estimates for shares of Journey Medical in a report released on Thursday...
MarketBeat·12d ago
News Placeholder
B. Riley Increases Earnings Estimates for Journey Medical
Journey Medical Corporation (NASDAQ:DERM - Free Report) - Analysts at B. Riley raised their FY2029 earnings per share (EPS) estimates for Journey Medical in a report issued on Thursday, November...
MarketBeat·14d ago
News Placeholder
HC Wainwright Forecasts Weaker Earnings for Journey Medical
Journey Medical Corporation (NASDAQ:DERM - Free Report) - Research analysts at HC Wainwright cut their FY2026 earnings estimates for Journey Medical in a research report issued to clients and...
MarketBeat·14d ago
News Placeholder
Journey Medical (NASDAQ:DERM) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS
Journey Medical (NASDAQ:DERM - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.05) by...
MarketBeat·16d ago
News Placeholder
Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Journey Medical (DERM) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·17d ago
News Placeholder
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates
Journey Medical (DERM) delivered earnings and revenue surprises of -12.50% and -0.39%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·17d ago
News Placeholder
Insights into Journey Medical's Upcoming Earnings
read more...
Benzinga·18d ago
News Placeholder
Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates
Guardian Pharmacy (GRDN) delivered earnings and revenue surprises of +4.17% and +6.63%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·19d ago
News Placeholder
electroCore, Inc. (ECOR) Reports Q3 Loss, Beats Revenue Estimates
electroCore (ECOR) delivered earnings and revenue surprises of -11.11% and +10.69%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·24d ago

Latest DERM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.